发明名称 COMPOSITION FOR NORMALIZATION OF LIPID METABOLISM AND REDUCING BODY MASS AND METHOD FOR ITS PREPARING
摘要 FIELD: pharmacy, medicinal biochemistry, nutrition. ^ SUBSTANCE: invention relates to an agent used in curative-prophylactic nutrition. Invention proposes composition for correction of the assimilation level of foodstuffs of lipid nature by a body that involves complex comprising equimolar water-soluble salt of chitosan with ascorbic, succinic and lipoic acids, substance of polyoxynaphthoquinone nature and marine echinoderms animals (Echinodermata), polyoxyphenolic compounds from grape bunches and trivalent chrome ions and a sweetening agent. As a sweetening agent fructose is used in its concentration in the end product 30-80%, not less. The content of substances of polyoxynaphthoquinone nature in the end product is 0.1 mg/ml, not less. The composition comprises trivalent chrome ions in the amount not exceeding the daily dose 50 mcg/24 h in a single intake. The composition can be prepared in form of syrup, gel, paste, tablet, powder or aerosol. Also, invention proposes a method for preparing the composition used in correction of the assimilation level of foodstuffs of lipid nature by a body. Method provides preparing the composition containing chitosan in the final concentration from 1% to 5%, substances of polyoxynaphthoquinone nature 0.1 mg/nl, not less, trivalent chrome ions in the amount not exceeding the daily dose 50 mcg/24 h in a single intake and fructose taken in the amount from 30% to 80%. Method for preparing the composition involves mixing chitosan with solution of ascorbic and succinic acid at temperature 15-50°C, and prepared mixture of chitosan with aqueous solution of ascorbic and succinic acid is kept for 10-36 h. Invention provides improving blood lipid spectrum, protects liver against adipose infiltration, promotes to reducing body mass, provides antioxidant protection of body. The composition can be used as a curative-prophylactic agent in obesity of 1-st and 2-d degree of atherosclerosis, heart coronary disease, in symptoms of "metabolic syndrome", liver adipose infiltration and adipose hepatosis. ^ EFFECT: valuable medicinal properties of composition. ^ 11 cl, 6 tbl, 2 ex
申请公布号 RU2290185(C1) 申请公布日期 2006.12.27
申请号 RU20050123709 申请日期 2005.07.26
申请人 MJASNIKOV DMITRIJ NIKOLAEVICH;KASHLINSKIJ ALEKS 发明人 MJASNIKOV DMITRIJ NIKOLAEVICH;KASHLINSKIJ ALEKS;BULANOV ALEKSANDR EVGEN'EVICH;KHASINA MAJJA ALEKSANDROVNA;ARTJUKOV ALEKSANDR ALEKSEEVICH
分类号 A61K31/722;A61K31/194;A61K31/375;A61K33/18;A61K35/56;A61K36/87;A61P3/00 主分类号 A61K31/722
代理机构 代理人
主权项
地址